Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.06
+0.02502.43%
Pre-market: 1.05-0.0050-0.47%07:41 EDT
Volume:1.92M
Turnover:2.00M
Market Cap:130.82M
PE:-1.56
High:1.07
Open:1.07
Low:1.03
Close:1.03
52wk High:3.06
52wk Low:1.00
Shares:124.00M
Float Shares:106.47M
Volume Ratio:0.98
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:7.18
PE(LYR):-1.40

Loading ...

Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
May 20, 2026

Correspondence

Form CORRESP - Correspondence
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2026

Major Issues Report

Form 8-K - Current report
Mar 20, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]